Search Constraints
Search Results
Select an image to start the slideshow
Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses
1 of 15
Induction of Anti-Tumor Immunity in an Immune Checkpoint
Inhibitor Resistant Murine Lung Cancer
2 of 15
Common gamma-chain (ϒc) cytokine-based fusion proteins forapplications in immunotherapy
3 of 15
Protein transfer-mediated modification of virus-like particles and plasma membrane vesicles: A means to adjuvant and deliver tumor antigens
4 of 15
Heat Shock Factor 1 Regulation of Multiple Myeloma Pathogenesis
5 of 15
Inhibiting VIP Receptor Signaling Promotes T Cell Mediated Immune Response in Murine Melanoma Models
6 of 15
Evaluation of tumor membrane vesicle (TMV) vaccine immunotherapy in a HER2+ TUBO murine breast cancer model
7 of 15
Elucidating the Role of Soluble Galectin-9 in B-cell Acute Lymphoblastic Leukemia Pathogenesis
8 of 15
An intratumoral immune niche sustains the anti-tumor immune response and supports the response to immunotherapy
9 of 15
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
10 of 15
Modulating Mitofusins to Enhance Therapeutic T Cell Expansion and Persistence
11 of 15
Understanding and Optimizing Gamma-Delta T cells as a Platform for Cellular Immunotherapies
12 of 15
MEK inhibition mediates immunomodulatory factors and cell populations in advanced biliary tract cancer
13 of 15
Strategies for engineering γδ T cells to treat pediatric cancers
14 of 15
Siglec-15 is required for evasion of immune response in acute lymphoblastic leukemia
15 of 15